Technology has made it possible for Stanford Medicine residents to continue learning and caring for patients safely during the COVID-19 era.
The COVID-19 pandemic gives new relevance to a synthetic substance developed by Stanford researchers that could help respiratory patients breathe easier.
A Stanford team is developing a bioscaffold that helps insulin-producing cells get enough oxygen when transplanted for diabetes treatment.
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
A NOVA special featured Rhiju Das and the OpenVaccine project, in which gamers help scientists find an RNA molecule configuration for a COVID-19 vaccine.
This New York Times video showcases Stanford Medicine's efforts to offer COVID-19 antibody tests to its doctors, nurses and other clinical workers.
Stanford psychologist Douglas Rait helps groups of Stanford Biodesign Innovation fellows hone their ability to work as a team, fueling their projects.
Stanford bioengineer Manu Prakash and his team have transformed full-face snorkel masks into reusable personal protective equipment for health care workers.
Stanford bioengineering researchers find that a motorized device that attaches around the ankle and foot can drastically reduce the energy cost of running.
Researchers are using artificial intelligence to detect abnormalities in the heart through an algorithm that assesses the rate that a heart pumps blood.
Stanford University researchers created a device that, if implanted in a brain, could help record the activity of thousands of neurons.
In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.
A new curriculum trains neurology residents to think like engineers in a factory — improving outcomes while reducing waste and lowering costs.
A Stanford oncologist discusses how to improve cancer diagnosis and treatment, including using predictive modeling, liquid biopsies and immunotherapy.
Ethical and legal issues accompany the potential benefits of using computer vision-based ambient intelligence in health care.
A team led by Howard Chang has contributed key technology to enable new experimental cancer therapy that uses CRISPR to edit immune cells.